What Makes COMPASS Pathways PLC Sponsored ADR (CMPS) a Strong Momentum Stock: Buy Now?

Does COMPASS Pathways PLC Sponsored ADR (CMPS) have what it takes to be a top stock pick for momentum investors? Let's find out.
Investor's Business Daily on MSN

How Trump sent psychedelics-tied Compass Pathways and others flying

Compass Pathways stock surged Monday after President Donald Trump signed an executive order tied to psychedelic drugs.
Barron's

COMPASS Pathways PLC ADR

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are ...

Compass Pathways Collaborates with Osmind to Advance Independent Clinic Readiness for Psychedelic Treatments

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation announced today it has entered into a collaboration with Osmind, the ...

7 Best Psychedelic Stocks and ETFs to Buy in 2026

President Trump's executive order is giving psychedelic stocks a boost. These companies are leaders in the industry.
Las Vegas Sun

Compass Pathways Announces U.S Grant Program for the Creation of Post-Approval COMP360 Provider Training

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today an invitation for U.S. based ...
Seeking Alpha

COMPASS Pathways Announces First Quarter 2023 Financial Results and Business Highlights

COMPASS Pathways plc (CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, reported its financial results for the ...
TMCnet

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

In accordance with NASDAQ Listing Rule 5635 (c) (4), the equity awards were approved by the Compensation and Leadership Development Committee of Compass's Board of Directors and were made as a ...
Agence France-Presse

Compass Pathways to Participate in Needham Virtual Psychedelics Forum on April 27, 2026

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that CEO Kabir Nath will ...
Seeking Alpha

Compass Pathways announces investigational COMP360 psilocybin treatment was well-tolerated in phase 2 study of post-traumatic stress disorder

LONDON, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Compass Pathways plc (CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, ...

How Much Upside is Left in COMPASS Pathways (CMPS)? Wall Street Analysts Think 136%

The mean of analysts' price targets for COMPASS Pathways (CMPS) points to a 136% upside in the stock. While this highly ...